Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avandia in Mild to Moderate Alzheimer's Disease
NCT00265148Phase 2Completed
- Sponsor
- GSK
- Start
- May 2004
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of rosiglitazone in Alzheimer's disease (AD), sponsored by GSK. Started May 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00265148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265148.